TotalMarketCap

Pharvaris

PHVSNasdaq NetherlandsHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.278 B

$32.70 -4.75%

Close of 6 Nov 2026

As of 6 Nov 2026, Pharvaris (PHVS) has a market capitalization of $2.28B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

65,210,590

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #83Xeris BiopharmaXERS$2.37B
  2. #84MBX BiosciencesMBX$2.34B
  3. #85PharvarisPHVS$2.28B
  4. #86NewAmsterdam PharmaNAMS$2.27B
  5. #87SepternaSEPN$2.22B

What if Pharvaris were worth as much as…

Open the what-if tool →

Gold $28.2T

$405,315.22

Per share 12,395× higher

Bitcoin $1.53T

$21,930.90

Per share 671× higher

Apple $5.02T

$71,997.10

Per share 2,202× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Pharvaris are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.